CVS Health Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.9% | +18.8% | -21.0% | +10.7% | +44.9% | +23.5% | +15.1% | -11.4% | -17.0% | -32.2% | +16.8% | |
| – | +8.3% | +18.3% | +0.2% | +9.6% | +60.8% | +1.6% | +1.6% | -5.9% | +2.8% | +5.3% | +0.2% | |
| – | +39.4% | -3.5% | +5.4% | +19.7% | +61.8% | -11.7% | +21.0% | -7.6% | +31.5% | -8.2% | -0.9% | |
| – | -66.5% | +276.1% | -178.5% | – | -93.4% | +136.9% | -48.8% | +361.4% | – | – | – | |
| – | +33.2% | +6.8% | -131.3% | – | – | +110.7% | +25.0% | +77.4% | -99.8% | +626.7% | -1,452.3% | |
| – | +10.8% | -6.0% | -13.8% | +6.2% | +20.6% | -0.8% | +3.4% | +8.2% | +11.1% | -8.2% | +1.8% | |
| – | +231.8% | -81.6% | +16.5% | +1,404.5% | -92.3% | +65.7% | -4.9% | -4.1% | +313.9% | -63.6% | -22.9% | |
| – | +22.4% | +16.8% | +11.4% | -0.5% | +27.7% | +0.8% | +0.0% | +10.7% | +7.7% | +7.7% | +0.7% | |
| – | +25.0% | -10.8% | -2.2% | -97.8% | – | +38.9% | +113.6% | -737.5% | -42.5% | +50.2% | – | |
| – | – | -105.5% | -2.6% | – | -113.9% | +6.6% | +63.4% | -54.6% | – | -36.2% | -135.2% | |
| – | – | -238.6% | -0.1% | – | -121.3% | +3.9% | +39.3% | -7.4% | – | -142.3% | +335.2% | |
| – | – | – | -277.6% | – | -30.7% | +31.2% | -24.3% | -62.7% | -878.5% | – | -147.9% | |
| – | +2.8% | +28.3% | -23.1% | +12.1% | +52.2% | +29.2% | +17.3% | -14.6% | -22.7% | -39.1% | +23.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.